Sivia Capital Partners, LLC

Position in MRK — Merck & Co., Inc.

CIK 2012032 Mill Valley, CA

Position in MRK

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$2,112,540

+$134,973 QoQ

Shares Held

16,440

0.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.29%

of 13F equity value

Holder Rank

#1,547

of 3,769 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Sivia Capital Partners, LLC holds $16,248,994 across 14 Drug Manufacturers - General names. MRK ranks #3 (13.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	3,555	$4,263,974
2	BMY	Bristol Myers Squibb Co	47,373	$2,729,632
3	MRK	Merck & Co., Inc. This page	16,440	$2,112,540
4	PFE	Pfizer Inc	82,650	$1,990,212
5	NVS	Novartis AG	6,151	$963,984
6	JNJ	Johnson & Johnson	3,459	$878,482
7	BIIB	Biogen Inc.	3,879	$838,096
8	GSK	GSK plc	10,340	$542,022

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,112,540	16,440	0.0%	Shares	Sole	2026-07-23
2026-03-31	$1,977,567	16,440	-28.5%	Shares	Sole	2026-05-13
2025-12-31	$2,420,243	22,993	+40.9%	Shares	Sole	2026-02-10
2025-09-30	$1,370,073	16,324	+42.0%	Shares	Sole	2025-10-20
2025-06-30	$909,865	11,494	+52.2%	Shares	Sole	2025-09-24
2025-03-31	$677,957	7,553	+9.0%	Shares	Sole	2025-04-14
2024-12-31	$689,296	6,929	+2.6%	Shares	Sole	2025-01-13
2024-09-30	$766,643	6,751	+4.1%	Shares	Sole	2024-10-11
2024-06-30	$802,719	6,484	-8.7%	Shares	Sole	2024-08-05
2024-03-31	$936,581	7,098	-0.1%	Shares	Sole	2024-04-19
2023-12-31	$774,914	7,108	—	Shares	Sole	2024-03-13
No filing history on record for this holder in this stock.